Eoin specialises in patents with a particular focus on advising pharmaceutical and biotechnology companies in relation to patent infringement and validity issues.

Eoin has extensive experience in cross-border patent litigation related to blockbuster pharmaceutical drugs representing IP owners, licensees, as well as generic and biosimilar manufacturers. With extensive international experience, Eoin has operated across numerous major jurisdictions.

Eoin’s expertise extends to the life cycle management of medicinal products, regulatory advice, and advising on European data and marketing exclusivity.

Eoin has advised a diverse range of clients, especially within the life sciences, technology and telecommunications sectors, on matters concerning the acquisition and licensing of intellectual property rights.

显示完整简历 隐藏完整简历

最新新闻和观点

酒店与休闲

Court of Appeal in Ireland grants interlocutory injunction restraining the launch of Teva’s generic apixaban product pending determination of appeal

2024年6月14日
Briefing

作者 Eoin Martyn

点击此处了解更多
专利与创新

Taylor Wessing bolsters Dublin office with hire of partner Eoin Martyn

2024年5月13日

作者 Eoin Martyn

点击此处了解更多
品牌与广告业

No clarity (yet) on whether rental can exhaust trade mark rights

2024年6月13日
Briefing

作者 Faziel Abdul

点击此处了解更多
酒店与休闲

The Digital Act for the healthcare sector in Germany: New requirements for the use of cloud computing services in the healthcare sector

2024年6月12日
Briefing

作者

点击此处了解更多

与我会面: